{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T20:58:33Z","timestamp":1782248313596,"version":"3.54.5"},"reference-count":30,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Astra-Zeneca"},{"name":"SOCALPAR"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Non-anemic iron deficiency (NAID) has been increasingly recognized as a potential factor affecting chronic obstructive pulmonary disease (COPD) outcomes. However, its prognostic role in COPD exacerbations and hospitalizations remains poorly understood. This study aimed to evaluate the prevalence of NAID in COPD patients, its impact on functional parameters, and its predictive value for exacerbations and hospitalizations. Methods: This prospective observational study included 238 patients with stable COPD and 60 age- and sex-matched smokers without COPD as a control group. NAID was defined as serum ferritin &lt; 100 ng\/mL or serum ferritin between 100 and 299 ng\/mL with transferrin saturation &lt; 20%. Clinical assessments included pulmonary function tests, 6 min walk distance (6MWD), handgrip strength, and fat-free mass index (FFMI). Patients were followed for 12 months to record moderate and severe COPD exacerbations. Cox regression analysis was used to determine the predictive value of NAID for exacerbations and hospitalizations. Results: NAID was present in 68.9% of COPD patients compared to 46.7% of smokers without COPD (p = 0.001). COPD patients with NAID had lower 6MWD (430 (330\u2013500) m vs. 462 (390\u2013510) m, p = 0.029), reduced FFMI (17.9 (15.5\u201320.2) kg\/m2 vs. 20.6 (17.6\u201322.6) kg\/m2, p &lt; 0.001), and weaker handgrip strength (26 (22\u201333) kg vs. 34 (27\u201340) kg, p &lt; 0.001) compared to non-NAID COPD patients. During the 12-month follow-up period, 140 patients developed moderate COPD exacerbations (107 in the NAID group), and 43 patients were hospitalized due to severe exacerbations (36 in the NAID group). Cox regression analysis showed that NAID was an independent predictor of moderate COPD exacerbations (HR 1.846, 95% CI 1.249\u20132.729, p = 0.002) and hospitalization (HR 2.537, 95% CI 1.129\u20135.703, p = 0.024) after adjusting for age, sex, lung function, and comorbidities. Conclusions: NAID is highly prevalent in COPD and is associated with worse exercise capacity, lower muscle mass, and increased exacerbation risk independently of sex and age. These findings suggest that NAID could be a valuable biomarker for risk stratification in COPD patients, warranting further research on potential therapeutic interventions targeting iron metabolism.<\/jats:p>","DOI":"10.3390\/jcm14124154","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T11:18:40Z","timestamp":1749640720000},"page":"4154","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Non-Anemic Iron Deficiency Predicts COPD Exacerbations and Hospitalizations: Results from a Prospective Cohort"],"prefix":"10.3390","volume":"14","author":[{"given":"Carlos A.","family":"Amado","sequence":"first","affiliation":[{"name":"Department of Pulmonology, Hospital Universitario Marqu\u00e9s de Valdecilla, 39005 Santander, Spain"},{"name":"Department of Medicine and Psychiatry, University of Cantabria, 39005 Santander, Spain"},{"name":"IDIVAL (Instituto de Investigaci\u00f3n Biom\u00e9dica de Cantabria), 39011 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9262-3247","authenticated-orcid":false,"given":"Cristina","family":"Ghadban","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Hospital Universitario Marqu\u00e9s de Valdecilla, 39005 Santander, Spain"},{"name":"Department of Medicine and Psychiatry, University of Cantabria, 39005 Santander, Spain"},{"name":"IDIVAL (Instituto de Investigaci\u00f3n Biom\u00e9dica de Cantabria), 39011 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1610-0530","authenticated-orcid":false,"given":"Juan","family":"Ag\u00fcero","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Hospital Universitario Marqu\u00e9s de Valdecilla, 39005 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7279-7643","authenticated-orcid":false,"given":"Bernardo A.","family":"Lav\u00edn","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Hospital Universitario Marqu\u00e9s de Valdecilla, 39005 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9570-5227","authenticated-orcid":false,"given":"Paula","family":"Mart\u00edn-Audera","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Hospital Universitario de Burgos, 09006 Burgos, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8896-8611","authenticated-orcid":false,"given":"Armando R.","family":"Guerra","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Hospital Universitario Marqu\u00e9s de Valdecilla, 39005 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Berja","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Hospital Universitario Marqu\u00e9s de Valdecilla, 39005 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nieves","family":"Aranda","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Hospital Universitario Marqu\u00e9s de Valdecilla, 39005 Santander, Spain"},{"name":"IDIVAL (Instituto de Investigaci\u00f3n Biom\u00e9dica de Cantabria), 39011 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Guzun","sequence":"additional","affiliation":[{"name":"IDIVAL (Instituto de Investigaci\u00f3n Biom\u00e9dica de Cantabria), 39011 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Isabel","family":"Insua","sequence":"additional","affiliation":[{"name":"IDIVAL (Instituto de Investigaci\u00f3n Biom\u00e9dica de Cantabria), 39011 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2531-3284","authenticated-orcid":false,"given":"Mayte","family":"Garc\u00eda-Unzueta","sequence":"additional","affiliation":[{"name":"Department of Medicine and Psychiatry, University of Cantabria, 39005 Santander, Spain"},{"name":"IDIVAL (Instituto de Investigaci\u00f3n Biom\u00e9dica de Cantabria), 39011 Santander, Spain"},{"name":"Department of Biochemistry, Hospital Universitario Marqu\u00e9s de Valdecilla, 39005 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"key":"ref_1","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (2024, December 24). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: 2025 Report. Available online: https:\/\/goldcopd.org\/2025-gold-report\/."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Farrell, L.A., O\u2019Rourke, M.B., Padula, M.P., Souza-Fonseca-Guimaraes, F., Caramori, G., Wark, P.A.B., Dharmage, S.C., and Hansbro, P.M. (2024). The Current Molecular and Cellular Landscape of Chronic Obstructive Pulmonary Disease (COPD): A Review of Therapies and Efforts towards Personalized Treatment. Proteomes, 12.","DOI":"10.3390\/proteomes12030023"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Amado, C.A., Mart\u00edn-Audera, P., Ag\u00fcero, J., Lav\u00edn, B.A., Guerra, A.R., Boucle, D., Ferrer-Pargada, D., Berja, A., Mart\u00edn, F., and Casanova, C. (2023). Circulating levels of mitochondrial oxidative stress-related peptides MOTS-c and Romo1 in stable COPD: A cross-sectional study. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1100211"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Amado, C.A., Mart\u00edn-Audera, P., Ag\u00fcero, J., Ferrer-Pargada, D., Josa Laorden, B., Boucle, D., Berja, A., Lav\u00edn, B.A., Guerra, A.R., and Ghadban, C. (2023). Alterations in circulating mitochondrial signals at hospital admission for COPD exacerbation. Chronic Respir. Dis., 20.","DOI":"10.1177\/14799731231220058"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Amado, C.A., Mu\u00f1oz, P., Garc\u00eda-Unzueta, M., Ag\u00fcero, J., Tello, S., Fueyo, P., Vega, C., Lav\u00edn, B.A., Guerra, R.A., and Casanova, C. (2021). High parathyroid hormone predicts exacerbations in COPD patients with hypovitaminosis D. Respir. Med., 182.","DOI":"10.1016\/j.rmed.2021.106416"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.pulmoe.2022.06.003","article-title":"Associations of serum sclerostin levels with body composition, pulmonary function, and exacerbations in COPD patients","volume":"30","author":"Amado","year":"2024","journal-title":"Pulmonology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/resp.12616","article-title":"Non-anaemic iron deficiency in COPD: A potential therapeutic target?","volume":"20","author":"Boutou","year":"2015","journal-title":"Respirology"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Rezvani, A., Masoompour, S.M., Azarpira, N., Monjazeb, R., Akbarzadeh, M., Salimi, M., and Shahriarirad, R. (2023). Serum levels of erythropoietin in patients with chronic obstructive pulmonary disease and anemia. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-34290-w"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jacc.2007.09.036","article-title":"Effect of intravenous iron sucrose on exercise tolerance in anaemic nonanemic patients with symptomatic chronic heart failure iron deficiency FERRIC-HF: A randomized controlled observer-blinded trial","volume":"51","author":"Okonko","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41569-023-00951-6","article-title":"Iron deficiency and supplementation in heart failure","volume":"21","author":"Cleland","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2147\/COPD.S182700","article-title":"Is iron deficiency modulating physical activity in COPD?","volume":"14","author":"Molina","year":"2019","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.7150\/ijms.46163","article-title":"The Significance of iron deficiency and anemia in a real-life COPD cohort","volume":"17","author":"Pizzini","year":"2020","journal-title":"Int. J. Med. Sci."},{"key":"ref_13","first-page":"261","article-title":"COPD: Iron Deficiency and Clinical Characteristics in Patients With and Without Chronic Respiratory Failure","volume":"11","author":"Hardang","year":"2024","journal-title":"Chronic Obstr. Pulm. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/resp.12591","article-title":"Non-anaemic iron deficiency impairs response to pulmonary rehabilitation in COPD","volume":"20","author":"Blanco","year":"2015","journal-title":"Respirology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.55519\/JAMC-01-12835","article-title":"Iron deficiency without anaemia in copd patients: Assessing exercise capacity and exacerbation frequency","volume":"36","author":"Abbasi","year":"2024","journal-title":"J. Ayub Med. Coll. Abbottabad"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Barbui, T., Thiele, J., Gisslinger, H., Finazzi, G., Vannucchi, A.M., and Tefferi, A. (2018). The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: Document summary and in-depth discussion. Blood Cancer J., 8.","DOI":"10.1038\/s41408-018-0054-y"},{"key":"ref_17","unstructured":"World Health Organization (WHO) (2023, January 10). Anaemia-How Is It Defined. Available online: https:\/\/www.who.int\/data\/nutrition\/nlis\/info\/anaemia."},{"key":"ref_18","first-page":"388","article-title":"Spanish Society of Pulmonology and Thoracic Surgery (SEPAR). Spirometry. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR)","volume":"49","author":"Calle","year":"2013","journal-title":"Arch. Bronconeumol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.arbres.2015.04.011","article-title":"SEPAR Guidelines for the evaluation and treatment of muscle dysfunction in patients with chronic obstructive pulmonary disease","volume":"51","author":"Barreiro","year":"2015","journal-title":"Arch. Bronconeumol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Zhang, H., Tian, W., Qi, G., and Wei, X. (2024). Sex-specific association of total mineral intake with pulmonary function in middle-aged and older adults with chronic obstructive pulmonary disease. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-79862-6"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Wacka, E., Nicikowski, J., Jarmuzek, P., and Zembron-Lacny, A. (2024). Anemia and Its Connections to Inflammation in Older Adults: A Review. J. Clin. Med., 13.","DOI":"10.3390\/jcm13072049"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.mad.2018.07.003","article-title":"Iron status in the elderly: A review of recent evidence","volume":"175","author":"Wawer","year":"2018","journal-title":"Mech. Ageing Dev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/bjh.16409","article-title":"The prevalence and associated mortality of non-anaemic iron deficiency in older adults: A 14 years observational cohort study","volume":"189","author":"Philip","year":"2020","journal-title":"Br. J. Haematol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1056\/NEJMra1401038","article-title":"Iron-deficiency anemia","volume":"372","author":"Camaschella","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.recesp.2015.08.017","article-title":"Iron status in chronic heart failure: Impact on symptoms, functional class and submaximal exercise capacity","volume":"69","author":"Enjuanes","year":"2016","journal-title":"Rev. Espanola Cardiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.ekir.2023.05.002","article-title":"A Randomized Trial of Intravenous Iron Supplementation and Exercise on Exercise Capacity in Iron-Deficient Nonanemic Patients with CKD","volume":"8","author":"Greenwood","year":"2023","journal-title":"Kidney Int. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/ajcn\/82.1.53","article-title":"Body composition and mortality in chronic obstructive pulmonary disease","volume":"82","author":"Schols","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Nickol, A.H., Frise, M.C., Cheng, H.Y., McGahey, A., McFadyen, B.M., Harris-Wright, T., Bart, N.K., Curtis, M.K., Khandwala, S., and O\u2019Neill, D.P. (2015). A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease. BMJ Open, 5.","DOI":"10.1136\/bmjopen-2015-007911"},{"key":"ref_29","first-page":"72","article-title":"Iron deficiency and risk of all-cause hospitalization in a clinical cohort of patients with COPD","volume":"12","author":"Kunitomo","year":"2025","journal-title":"Chronic Obstr. Pulm. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"616S","DOI":"10.1093\/jn\/131.2.616S","article-title":"Iron and its relation to immunity and infectious disease","volume":"131","author":"Oppenheimer","year":"2001","journal-title":"J. Nutr."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/12\/4154\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:50:22Z","timestamp":1760032222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/12\/4154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":30,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["jcm14124154"],"URL":"https:\/\/doi.org\/10.3390\/jcm14124154","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,11]]}}}